| RS1686177024 |
ITGA6
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS16861801 |
MASP1
|
Health Risk |
Conflicting classifications of pathogenicity |
3MC syndrome 1, MASP1-related disorder |
| RS1686193080 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1686209873 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1686210975 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1686375136 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1686383386 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1686426425 |
AGPS
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS1686427549 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS1686492794 |
ATF6
|
Health Risk |
Likely pathogenic |
— |
| RS1686505064 |
GPX4
|
Health Risk |
Likely pathogenic |
— |
| RS1686551975 |
TTC21B
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1686562488 |
HIBCH
|
Health Risk |
Pathogenic |
3-hydroxyisobutyryl-CoA hydrolase deficiency, 3-hydroxyisobutyryl-CoA hydrolase deficiency |
| RS1686661157 |
EXOC8
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, seizures |
| RS1686687362 |
KYNU
|
Health Risk |
Likely pathogenic |
— |
| RS1686753674 |
ITGA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa, junctional 6 |
| RS1686756273 |
NR4A2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism, Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism |
| RS1686809735 |
TTC21B
|
Health Risk |
Pathogenic |
Nephronophthisis 12, Nephronophthisis 12 |
| RS1686811023 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1686814382 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1686821540 |
NR4A2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS1686838527 |
TTC21B
|
Health Risk |
Likely pathogenic |
Nephronophthisis 12, Nephronophthisis 12 |
| RS16869016 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1686926761 |
ITGA6
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS1686972152 |
TTC21B
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Jeune thoracic dystrophy |
| RS1686989669 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1686990557 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1686990676 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1686991727 |
RPL5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1687002124 |
DIPK1A;RPL5
|
Health Risk |
Pathogenic |
— |
| RS1687004626 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS1687054029 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS1687057544 |
NLRC4
|
Health Risk |
Pathogenic |
Periodic fever-infantile enterocolitis-autoinflammatory syndrome, Periodic fever-infantile enterocolitis-autoinflammatory syndrome |
| RS1687102215 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1687120632 |
RPL5;DIPK1A
|
Health Risk |
Pathogenic |
— |
| RS1687123286 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS1687164164 |
CALM2
|
Health Risk |
Pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1687178005 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1687210 |
EIF2B5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Vanishing white matter disease |
| RS1687223389 |
TMEM237
|
Health Risk |
Pathogenic |
Joubert syndrome 14, Joubert syndrome 14 |
| RS1687252 |
DVL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1687295837 |
ITGA4;CERKL
|
Health Risk |
Likely pathogenic |
— |
| RS1687367661 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS1687461276 |
HECW2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1687461391 |
HECW2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1687461840 |
HECW2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1687511235 |
SATB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1687511465 |
SATB2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1687515795 |
SATB2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1687516101 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS1687571331 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1687613797 |
HECW2
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1687613913 |
HECW2
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1687614121 |
HECW2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1687615194 |
LRP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1687649007 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS1687663690 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS1687693219 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1687748823 |
TET3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1687767627 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1687790149 |
CERKL
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1687796533 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1687797608 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS1687798117 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS1687828601 |
HECW2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1687838639 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS1687843772 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1687845450 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1687854945 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1687957552 |
SATB2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1687958384 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1687959221 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 62 |
| RS1687959307 |
SATB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1688010642 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS1688012992 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1688050712 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS1688068423 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS1688078187 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688079577 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS1688101794 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS1688101934 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1688103803 |
SATB2
|
Health Risk |
Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1688103993 |
SATB2
|
Health Risk |
Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1688106559 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1688108235 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1688108689 |
SATB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1688108762 |
SATB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS16881446 |
HS3ST1
|
Health Risk |
risk factor |
Arteriosclerosis disorder, Coronary artery disorder |
| RS1688188231 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1688203788 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688218776 |
PROC
|
Health Risk |
Pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1688231067 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688231158 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688243975 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1688249384 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688258933 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688259777 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS1688268302 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1688273707 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS1688274077 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |